Official UK procurement notice
NHS National Framework Agreement for the Supply of Recombinant Von Willebrand Factor
Authority: The NHS Commissioning Board (operating under the name of NHS England) (NHS & healthcare)
What is being bought
Published requirement descriptionNHS National Framework Agreement for the supply of Recombinant Von Willebrand Factor. The framework will commence on 1 February 2021 for a period of 5 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 43 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.
CPV: Blood coagulants · Pharmaceutical products
How this framework works
From the published notice- Bids received
- 1 bids received · 1 suppliers appointed
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (3)
- Security of Supply: 20%
- Ease of use: 15%
- price: 65%
Published award criteria (3)
- Security of Supply: 20%
- Ease of use: 15%
- Price: 65%
- Price carries 65 of 100 points: a 10% discount moves about 6.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “NHS National Framework Agreement for the Supply of Recombinant Von…” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 27 Jan 2021, 17:14 GMT
- Last source update
- 27 Jan 2021, 17:14 GMT
- Authority reference
CM/PHS/20/5624- FTS notice number
2021/S 000-001672- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-028ddeFind a Tender
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Contract 001672-2021-1
- Signed
- 12 Jan 2021
- Value
- £1
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Framework contractors & participating bidders
1 commercial party on the notice- Shire Pharmaceuticals LtdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.